0001564590-19-009573.txt : 20190429 0001564590-19-009573.hdr.sgml : 20190429 20190327160120 ACCESSION NUMBER: 0001564590-19-009573 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SCYNEXIS INC CENTRAL INDEX KEY: 0001178253 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562181648 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 BUSINESS PHONE: 201-884-5485 MAIL ADDRESS: STREET 1: 1 EVERTRUST PLAZA STREET 2: 13TH FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07302-6548 CORRESP 1 filename1.htm scyx-corresp.htm

SCYNEXIS, Inc.

1 Evertrust Plaza, 13th Floor

Jersey City, NJ 07302-6548

 

 

 

Via Edgar

 

March 27, 2019

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC  20549

 

Attn:  Tania Aldave

 

Re:

SCYNEXIS, Inc.  
Registration Statement on Form S-3

Filed March 22, 2019

File No. 333-230449

 

Ladies and Gentlemen:

The undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (the “Filing”) to become effective at 4:00 p.m., Eastern Time, on March 29, 2019, or as soon thereafter as is practicable.

Sincerely,

/s/ Eric Francois

Eric Francois

Chief Financial Officer

cc:

Marco Taglietti, M.D, SCYNEXIS, Inc.

Matthew B. Hemington, Cooley llp

Brett D. White, Cooley llp